Efficacy of Infliximab in Patients with Refractory Uveitis Associated with Behcet Disease

Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab.

Sirs, Ocular involvement is a very common manifestation of Behçet’s disease (BD) and recurrent attacks of eye inflammation result in structural changes leading to loss of vision if left untreated. Anti-TNF-α agents have shown a rapid and effective suppression of ocular manifestations of BD, especially in cases refractory to conventional treatment with immunosuppressive drugs (1-10). We describe...

evaluation of fat atrophy in patients with dermis fat graft of orbit by ct-scan

چکیده ندارد.

Infliximab for Refractory Noninfectious Uveitis

Kruh et al. set out to establish whether infliximab is safe and effective for the treatment of refractory noninfectious uveitis. They found that the drug—a monoclonal antibody used in treating several chronic inflammatory diseases—induced a high rate of complete clinical remission in recalcitrant uveitis and was well tolerated by most patients. In this retrospective, interventional, noncomparat...

modern surgical techniques in treatment of patients with cleft lip & cleft palate

چکیده ندارد.

Successful Treatment of Refractory Behçet's Disease with the TNF-α Blocker Infliximab